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Abstract
Aims
Gestational diabetes (GDM) is often accompanied by maternal overweight. Our aim was to
evaluate the separate and concomitant effects of GDM and maternal overweight/obesity on
perinatal outcomes.
Methods
We used the Finnish Medical Birth Register to identify all 24,577 women with a singleton
pregnancy who delivered in 2009 in Finland and underwent an oral glucose tolerance test
(OGTT). Women were divided into groups according to the result of OGTT (GDM/no GDM)
and pre-pregnancy body mass index (BMI): normal weight (�24.9 kg/m2), overweight
(25.0–29.9 kg/m2), and obese (�30.0 kg/m2). Primary outcomes included macrosomia, cae-
sarean delivery, and treatment at neonatal ward. Normal weight women without GDM con-
stituted the reference group.
Results
Compared to reference group, overweight or obese women without GDM had an increased
risk of macrosomia [odds ratio adjusted for age, parity, smoking and socio-economic status
(aOR)1.18 (95% CI 1.09–1.28) and 1.50 (95% CI 1.19–1.88)], and caesarean delivery
[aORs 1.17 (95% CI 1.07–1.28) and 1.52 (95% CI 1.37–1.69)], respectively. In normal
weight GDM women the risk of macrosomia [aOR 1.17 (95% CI 0.85–1.62)] and caesarean
delivery [aOR 1.10 (95% CI 0.96–1.27)] was not significantly increased as compared to nor-
mal weight women without GDM. GDM increased the risk of treatment at neonatal ward in
all BMI categories and maternal obesity without GDM was also a risk factor for treatment at
neonatal ward. Interaction p values between BMI and GDM on these outcomes were
<0.001.
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Conclusions
Maternal overweight and obesity without GDM increased the risk of macrosomia and cae-
sarean delivery when compared to the reference group. These risks were amplified when
overweight/obesity was accompanied by GDM. Obesity without GDM was a risk factor for
treatment at neonatal ward; GDM increased this risk in all BMI categories. Our results sug-
gest that especially maternal obesity should be considered as a risk factor for adverse preg-
nancy outcomes and GDM further amplifies this risk.
Introduction
The incidence of gestational diabetes mellitus (GDM) is increasing together with maternal
obesity [1]. For example, In Finland, the proportion of overweight (pre-pregnancy body mass
index (BMI) 25.0–29.9 kg /m2) and obese (BMI�30 kg/m2) mothers has substantially
increased during the 21st century; the rate of overweight mothers increased from 18.8% to
35.6% and that of obese mothers from 7.5% to 13.2% between 1990 and 2013, respectively
[2,3]. The incidence of GDM was 19.0% in 2017 in Finland [3]. The European Perinatal Health
Report (2010) stated that the proportion of overweight or obese mothers commonly varies
from 27% to 37% in European countries [4]. Obesity complicates both pregnancy and delivery,
and it increases the costs of maternal care [5,6].
While maternal obesity is a key risk factor of GDM, it is also an independent predictor of
adverse pregnancy outcomes including preeclampsia, primary caesarean delivery, and fetal
macrosomia [7]. Maternal obesity has been found to be associated with increased cord C-pep-
tide concentration as a marker of fetal hyperinsulinemia and neonatal adiposity as a marker of
macrosomia [8,9]. In addition, it is also a risk factor for childhood obesity and long-term meta-
bolic disorders [10].
GDM is often accompanied by overweight or obesity, and the risk of adverse perinatal out-
come is highest when these conditions occur together [7]. Previously, it has been shown that
both GDM in normal weight woman and maternal obesity without GDM are independent risk
factors for adverse perinatal outcome [11,12]. Using the present population-based register
study, we investigated the significance of maternal GDM and overweight or obesity alone as
well as both conditions combined on the outcome of pregnancy including the incidence of
neonatal macrosomia, caesarean delivery, and the need for treatment at neonatal ward.
Materials and methods
The present study was based on the Finnish Medical Birth Register (MBR), which includes
detailed data of the course and complications of pregnancy and delivery along with the perina-
tal health of the newborn. All pregnancies resulting in a live birth and stillbirth at a gestational
age of 22 weeks or more or weighing 500 g or more are included in the MBR. For each delivery
in Finland, a structured form for the MBR is completed by the delivery hospital within seven
days of delivery. The data are checked at the MBR, and the hospital will be contacted for infor-
mation suspected of being incorrect or missing. Data are completed through a linkage to the
Population Register Centre on live births and the Statistics of Finland on stillbirths and infant
deaths. The MBR is complete after these linkages, and its data quality has been shown to be
high [13,14]. Since 2004, the MBR has included information on if an oral glucose tolerance test
(OGTT) for both the screening and diagnosis of GDM was performed, if the result was
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The new Finnish national guidelines launched in 2008 recommend that all women should
be screened for GDM, excluding those with a very low risk (primiparous women of normal
weight under 25 years of age, without a history of diabetes in first-degree relatives, or multipa-
rous women of normal weight less than 40 years of age, with no previous GDM or macrosomic
infants). These guidelines were the same as recommended by the American Diabetes Associa-
tion at the time of the study. A 2-h 75-g oral OGTT is mainly performed between 24 and 28
gestational weeks. For high-risk groups (prior GDM, BMI�35 kg/m2, or polycystic ovary syn-
drome with insulin resistance), OGTT is recommended between 12 and 16 gestational weeks.
In the case of a normal result, OGTT should be repeated between 24 and 28 gestational weeks.
The cut-off values for venous plasma glucose concentrations were 5.3, 10.0, and 8.6 mmol/l at
the baseline after an overnight fast and at 1 and 2 h after the glucose load, respectively. The
diagnosis of GDM was set after one or more values equal to or greater than the cut-off value.
According to the prevailing national guidelines, after the diagnosis of GDM, women receive
dietary and lifestyle counselling and begin self-monitoring of glucose concentrations. Insulin
therapy is begun if plasma glucose concentrations repeatedly exceeds the target levels (5.5
mmol/l fasting and/or 7.8 mmol/l at 1h postprandial). The use of oral anti-diabetic agents was
occasional and not included in the guidelines [15].
The study population consisted of women with a singleton pregnancy and OGTT per-
formed during pregnancy (n = 24,577). Those with abnormal OGTT results (n = 5,680, 23.0%)
were identified as having GDM, and the others with normal OGTT results acted as controls
(n = 18,897, 77.0%). Both groups were further divided into subgroups, according to their self-
reported pre-pregnancy BMI, which was recorded at the first antenatal visit: normal weight
(BMI�24.9 kg/m2), overweight (BMI 25.0–29.9 kg/m2), and obese (BMI�30 kg/m2). Pre-
pregnancy BMI was calculated as an individual’s pre-pregnancy weight divided by the square
of her height, as recorded by the MBR. Self-reported smoking, weight and hence BMI is
recorded in the first antenatal visit in maternal health care units, which is practically always
during the first trimester (mean 10th gestational week). (Fig 1).
Socioeconomic status was based on maternal occupation during pregnancy, and this infor-
mation is collected from the delivery hospitals with the MBR form. Coding was based on
national standards published by Statistics Finland and were divided into four different groups:
1) Upper-level employees with administrative, managerial, professional and related occupa-
tions, 2) Lower level employees with administrative and clerical occupations, 3) Manual work-
ers and 4) Others including for example home mothers, students, pensioners, and self-
employed persons [16].
The primary outcome included the incidence of macrosomia, which was defined as large-
for-gestational-age (birth weight over +2 standard deviation of the mean) by using the Finnish
sex- and gestational age-specific values [17], the rate of caesarean deliveries, and treatment in
the neonatal ward. The secondary outcomes were the rates of preterm (<37 +0 gestational
weeks) delivery, delivery induction, Apgar score at 5 min, neonatal hypoglycemia, which was
defined according to the clinical diagnosis set by a pediatrician (ICD-10 code P70.4), and peri-
natal mortality defined as stillbirth or death within 7 days after birth.
All statistical analyses were performed using the SAS version 9.3. Categorical variables were
reported as frequencies (%), and the Pearson’s χ2 test was used to compare the difference in
proportions. A logistic regression analysis was used to calculate both the odds ratio (OR) and
95% confidence intervals (CI) for the risk of developing outcomes associated with GDM and
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BMI. The interaction test was performed to calculate the possible interaction between GDM
and obesity. Women of normal weight with normal glucose tolerance were used as a reference
group. Adjusted odds ratios (aOR) with 95% CIs were calculated to evaluate the independent
associations of maternal age and parity as well as smoking and socioeconomic status with out-
come variables in each BMI/GDM group. The analysis code is available from: http://doi10.
17605/osf.io/cxq54. (S1 File).
Results
In 2009, there were 59,057 singleton deliveries in Finland. The mean age of the mothers was
30.0 years, and the mean pre-pregnancy BMI was 24.3 kg/m2. The rate of primiparity was 42%.
The incidence of an abnormal OGTT result was 9.6% in the whole population.
OGTT was performed for 24,577 (42%) mothers, and GDM was diagnosed by an abnormal
result in 23% of them (n = 5,680). Of all the women having OGTT performed, 10,332 (42%)
were normal weight, 8,732 (36%) were overweight, and 5,513 (22%) were obese. The baseline
characteristics of the study population are listed in Table 1.
The incidence of GDM was 17.0% in normal weight, 21.6% in overweight, and 36.9% in
obese women (Table 2). Table 2 shows the incidence of primary outcomes in BMI categories
in both the GDM and non-GDM-groups. The incidence of macrosomia was not significantly
increased in normal weight women with GDM as compared to normal weight women without
Fig 1. Flowchart.
https://doi.org/10.1371/journal.pone.0221549.g001
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GDM. The finding remained the same after adjusting for maternal age, parity, smoking, and
socioeconomic status (aOR 1.17, 95% CI 0.85–1.62) (Table 3). Both being overweight or obese
without GDM were associated with significantly increased risk of macrosomia with aORs of
1.18 (95% CI 1.09–1.28) and 1.50 (95% CI 1.19–1.88), respectively. Concomitant GDM further
increased the risk (Table 3).
The risk of caesarean delivery was similar in women of normal weight with or without
GDM (Table 2). Both being overweight and obese without GDM associated with an increased
risk of caesarean delivery with aORs of 1.17 (95% CI 1.07–1.28) and 1.52 (95%CI 1.37–1.69),
respectively (Table 3). GDM substantially increased the risk of caesarean delivery in both over-
weight and obese women (Table 2), and the adjustment further strengthened the finding
(Table 3). The risk of elective caesarean delivery was not increased in overweight women with-
out GDM, aOR 1.02 (95%CI 0.89–1.17), but their risk of acute caesarean delivery was
increased, aOR 1.26 (95% CI 1.13–1.40). Overweight with GDM and obesity with or without
GDM increased the risk of both elective and acute caesarean deliveries (Table 3).
The need for treatment at neonatal ward was significantly increased in babies of women
with GDM in all BMI categories (Table 2), with the aORs being 1.44 (95% CI 1.22–1.71) for
those of normal weight, 1.67 (95% CI 1.42–1.96) for those who were overweight, and 2.32
(95% CI 2.01–2.68) for obese women. Obesity, but not being overweight, without GDM was
associated with need for treatment at neonatal ward, with the aOR being 1.45 (95% CI 1.27–
1.66) (Table 3). Logistic regression was performed by adjusting additionally with neonatal
hypoglycemia: the risk of treatment at neonatal ward was still increased in normal weight
GDM women, aOR 1.45 (95%CI 1.21–1.75), overweight GDM women, aOR 1.69 (95%CI
1.42–2.01) and obese GDM women, aOR 2.53 (95%CI 2.17–2.96). Obesity, but not overweight
Table 1. The baseline characteristics of the mothers undergone OGTT.
No GDM GDM
n = 18897 n = 5680 p-value�
Age (years)
<19 310 (1.6) 94 (1.7)
20–29 8780 (46.5) 2142 (37.7) <0.001
30–39 8899 (47.1) 2991 (52.6)
�40 908 (4.8) 453 (8.0)
Parity
Primiparous 8762 (46.4) 2101 (37.0) <0.001
Multiparous 10 171 (53.6) 3579 (63.0)
SES�
I Upper level employees 3345 (17.7) 874 (15.4)
II Lower level employees 6579 (34.8) 1952 (34.4) <0.001
III Manual workers 2452 (13.0) 865 (15.2)
IV Others 6521 (34.5) 1989 (35.0)
BMI��
�24.9 kg/m2 8573 (45.4) 1759 (31.0)
25.0–29.9 kg/m2 6848 (36.2) 1884 (33.2) <0.001
�30 kg/m2 3476 (18.4) 2037 (35.9)
Smoking 2769 (14.7) 1056 (18.6) <0.001
Data are n (%)
�Sosioeconomic status
��Body Mass Index
https://doi.org/10.1371/journal.pone.0221549.t001
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without GDM increased the risk of need for treatment at neonatal ward, the corresponding
aORs being 1.38 (95%CI 1.21–1.59) and 1.10 (95%CI 0.98–1.24), respectively.
The incidence of secondary outcomes, according to the BMI and OGTT categories, are
listed in Table 4, and their ORs and aORs are shown in Table 5. GDM was associated with the
risk of delivery inductions in all BMI categories and both overweight and obesity without
GDM increased the risk of delivery inductions. The risk of preterm delivery was increased in
women with GDM in all BMI categories. GDM in normal weight and obese women, but not in
overweight women, was associated with 5min Apgar score below 7. The risk of neonatal hypo-
glycemia was increased in women with GDM in all BMI categories, and also in obese women
without GDM (Table 5).
The interaction between GDM and BMI was statistically significant for all variables
(p<0.001 for macrosomia, caesarean delivery, NICU treatment, delivery induction, preterm
Table 2. The incidence of primary outcomes according to pre-pregnancy BMI and the GDM status.
BMI�24.9 kg/m2 BMI 25–29.9 kg/m2 BMI�30 kg/m2
n = 10332 n = 8732 n = 5513
No GDM GDM No GDM GDM No GDM GDM
n (%) 8573(83.0) 1759(17.0) p-value� 6848(78.4) 1884(21.6) p-value� 3476(63.1) 2037(36.9) p-value�
Macrosomia 199(2.3) 48(2.7) 0.308 193(2.8) 83(4.4) <0.001 129(3.7) 135(6.6) <0.001
Caesarean delivery (CS), all 1369(16.0) 308(17.5) 0.110 1143(16.7) 396(21.0) <0.001 684(19.7) 515(25.3) <0.001
Elective CS 495(5.8) 114(6.5) 0.25 386(5.6) 162(8.6) <0.001 250(7.2) 198(9.7) 0.001
Acute CS 874(10.2) 194(11.0) 0.295 757(11.1) 234(12.4) 0.098 434(12.5) 317(15.6) 0.001
Treatment at neonatal ward 676(7.9) 192(10.9) <0.001 574(8.4) 225(11.9) <0.001 365(10.5) 319(15.7) <0.001
Data are n (%)
�comparison within the same BMI category
https://doi.org/10.1371/journal.pone.0221549.t002
Table 3. The Odds Ratios (OR) and adjusted ORs of the primary outcome according to pre-pregnancy BMI and the GDM status.
BMI�24.9 kg/m2 BMI 25–29.9 kg/m2 BMI�30 kg/m2
n = 10332 n = 8732 n = 5513
No GDM GDM No GDM GDM No GDM GDM
n (%) 8573 (83.0) 1759 (17.0) 6848 (78.4) 1884 (21.6) 3476 (63.1) 2037 (36.9)
OR OR aOR OR aOR OR aOR OR aOR OR aOR
Macrosomia 1 1.18
(0.86–
1.62)
1.17
(0.85–
1.62)
1.22
(1.00–
1.49)
1.18
(1.09–
1.28)
1.94
(1.49–
2.52)
1.79
(1.38–
2.33)
1.62
(1.30–
2.03)
1.50
(1.19–
1.88)
2.99
(2.39–
3.74)
2.72
(2.17–
3.42)
Caesarean delivery (CS),
all
1 1.12
(0.98–
1.28)
1.10
(0.96–
1.27)
1.05
(0.97–
1.15)
1.17
(1.07–
1.28)
1.40
(1.24–
1.59)
1.53
(1.34–
1.74)
1.29
(1.16–
1.43)
1.52
(1.37–
1.69)
1.78
(1.59–
2.00)
2.04
(1.81–
2.30)
Elective CS 1 1.13
(0.92–
1.34)
1.06
(0.86–
1.31)
0.97
(0.85–
1.12)
1.02
(0.89–
1.17)
1.54
(1.28–
1.85)
1.44
(1.20–
1.74)
1.26
(1.08–
1.48)
1.36
(1.16–
1.59)
1.76
(1.48–
2.09)
1.67
(1.40–
1.99)
Acute CS 1 1.09
(0.93–
1.29)
1.12
(0.95–
1.33)
1.09
(0.99–
1.21)
1.26
(1.13–
1.40)
1.25
(1.07–
1.46)
1.49
(1.27–
1.74)
1.26
(1.11–
1.42)
1.55
(1.37–
1.76)
1.62
(1.41–
1.87)
2.06
(1.79–
2.38)
Treatment at neonatal
ward
1 1.43
(1.21–
1.69)
1.44
(1.22–
1.71)
1.07
(0.95–
1.20)
1.11
(0.99–
1.25)
1.58
(1.35–
1.86)
1.67
(1.42–
1.96)
1.37
(1.20–
1.56)
1.45
(1.27–
1.66)
2.18
(1.89–
2.51)
2.32
(2.01–
2.68)
Data are OR (95%CI), aOR = OR adjusted for age, parity, smoking and socio-economic status
https://doi.org/10.1371/journal.pone.0221549.t003
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delivery and neonatal hypoglycemia, and p = 0.020 for 5 min Apgar<7), except perinatal mor-
tality (p = 0.230).
Discussion
In this large, population-based study, obese women without GDM had an increased risk of
both macrosomia and caesarean delivery, when compared to normal weight women without
GDM. Also in overweight women these risks were slightly, but significantly increased. The
risks were further amplified when overweight or obesity were accompanied by GDM. The
need for treatment at neonatal ward was increased in the babies of women with GDM in all
weight categories and in obese women without GDM. Compared to the reference group, the
risk of macrosomia and caesarean delivery was not significantly increased in normal weight
women counselled for GDM.
Table 4. The incidence of secondary outcomes according to the pre-pregnancy BMI and the GDM status.
BMI�24.9kg/m2 BMI 25–29.9kg/m2 BMI�30kg/m2
n = 10332 n = 8732 n = 5513
No GDM GDM No GDM GDM No GDM GDM
n (%) 8573(83.0) 1759(17.0) p-value� 6848(78.4) 1884(21.6) p-value� 3476(63.1) 2037(36.9) p-value�
Delivery induction 1430(16.7) 392(22.3) <0.001 1333(19.5) 499(26.5) <0.001 895(25.7) 739(36.3) <0.001
Preterm delivery 313(3.7) 82(4.7) 0.044 221(3.2) 95(5.0) <0.001 141(4.1) 113(5.7) 0.011
5min Apgar <7 52(0.6) 20(1.1) 0.015 63(0.9) 14(0.7) 0.467 41(1.2) 25(1.2) 0.875
Neonatal hypoglycemia 125(1.5) 224(12.7) <0.001 110(1.6) 257(13.6) <0.001 71(2.0) 313(15.4) <0.001
Perinatal mortality 19(0.2) 4(0.2) 0.963 15(0.2) 8(0.4) 0.123 11(0.3) 7(0.3) 0.864
Data are n (%)
�comparison within the same weight group
https://doi.org/10.1371/journal.pone.0221549.t004
Table 5. The Odds Ratios (OR) and adjusted ORs of the secondary outcome according to the pre-pregnancy BMI and the GDM status.
BMI�24.9kg/m2 BMI 25–29.9kg/m2 BMI�30kg/m2
n = 10332 n = 8732 n = 5513
No GDM GDM No GDM GDM No GDM GDM
n (%) 8573
(83.0)
1759 (17.0) 6848 (78.4) 1884 (21.6) 3476 (63.1) 2037 (36.9)
OR OR aOR OR aOR OR aOR OR aOR OR aOR
Delivery induction 1 1.43
(1.26–1.62)
1.42
(1.25–1.61)
1.21
(1.11–
1.31)
1.21
(1.11–
1.31)
1.80
(1.60–2.02)
1.77
(1.57–1.99)
1.73
(1.58–
1.90)
1.73
(1.57–
1.90)
2.84
(2.56–3.16)
2.79
(2.50–3.10)
Preterm delivery 1 1.29
(1.01–1.65)
1.29
(1.00–1.67)
0.88
(0.74–
1.05)
0.91
(0.77–
1.09)
1.40
(1.11–1.77)
1.45
(1.14–1.83)
1.12
(0.91–
1.37)
1.17
(0.96–
1.45)
1.55
(1.24–1.93)
1.62
(1.30–2.03)
5min Apgar <7 1 1.88
(1.12–3.16)
1.90
(1.13–3.19)
1.52
(1.05–
2.20)
1.58
(1.09–
2.28)
1.23
(0.68–2.22)
1.30
(0.72–2.35)
1.96
(1.30–
2.95)
2.07
(1.37–
3.13)
2.04
(1.26–3.29)
2.20
(1.35–3.56)
Neonatal
hypoglycemia
1 9.86
(7.87–
12.36)
9.85
(7.86–
12.34)
1.10
(0.85–
1.43)
1.10
(0.85–
1.43)
10.68
(8.57–
13.31)
10.65
(8.53–
13.29)
1.41
(1.05–
1.89)
1.40
(1.05–
1.89)
12.27
(9.91–
15.19)
12.18
(9.81–
15.11)
Perinatal mortality 1 1.03
(0.35–3.02)
0.92
(0.31–2.72)
0.99
(0.50–
1.95)
0.97
(0.49–
1.92)
1.92
(0.84–4.39)
1.65
(0.71–3.80)
1.43
(0.68–
3.01)
1.36
(0.64–
2.90)
1.55
(0.65–3.70)
1.28
(0.53–3.10)
Data are OR (95%CI) and aOR (95%CI), aOR = OR adjusted for age, parity, smoking and socio-economic status
https://doi.org/10.1371/journal.pone.0221549.t005
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The main strength of our study is the large, population-based dataset and a high rate of
validity [13,14]. However, despite the introduction of comprehensive GDM screening, only
42% of the mothers underwent OGTT in Finland in 2009. The new screening protocol had
been launched one year prior, but our results show that it had not been fully implemented at
that time. Thereafter, coverage has increased annually, reaching 66% in 2017, which has led to
increase in the incidence of GDM [3]. It has been estimated that approximately 80% of the
Finnish pregnant women meet the criteria of GDM screening according to the current guide-
lines. Our study may thus not be representative of all pregnant women who should have
undergone OGTT and therefore, we included only women whose glucose metabolism was
tested during pregnancy to increase the reliability of the results. The register-based data did
not allow us to evaluate the significance of pregnancy weight gain or maternal glycemic con-
trol, both of which are important for outcome estimates [18–20]. Data concerning GDM risk
factors like macrosomia and GDM in prior pregnancies or family history of diabetes were not
neither available.
The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study showed a positive
association between increasing maternal glycemic concentrations and macrosomia defined by
a birth weight above the 90th percentile [18]. The recent results of the HAPO study group
revealed that GDM and obesity—both alone and combined—are associated with adverse preg-
nancy outcomes and increased risk of macrosomia and primary caesarean, even in women of
normal weight with GDM [7]. Contrary to the HAPO study, we found the risk of macrosomia
and caesarean delivery in normal weight women with GDM to be comparable to normal
weight women without GDM. Because no interventions for mild GDM were included in the
HAPO study protocol, women did not receive optimal treatment [18]. By contrast, according
to the Finnish uniform guidelines, all women with abnormal OGTT results in our study
received dietary counseling and began self-monitoring of their blood glucose concentrations
as part of their primary care. Women who repeatedly exceeded the target glucose concentra-
tions were given insulin treatment. Our study represents the effect of implementation of the
national guidelines in clinical practice and demonstrates that, through treatment and follow-
up of GDM, the risk of macrosomia and caesarean delivery in normal weight women with
GDM is comparable to those of the background population. The finding is also in line with the
study of Landon et al. which revealed that the treatment of mild GDM decreased the rate of
macrosomia, caesarean delivery, and hypertensive complications of pregnancy [21].
Recently, several studies have indicated that maternal obesity is an independent risk factor
for neonatal macrosomia [7,19,22,23]. In our study, the risk of macrosomia was slightly, but
significantly increased in overweight women and significantly increased in obese women with-
out GDM, which is in line with previous studies.
In line with the study of Wahabi et al., our study revealed equal risk of macrosomia and cae-
sarean delivery in women of normal weight with or without GDM [12]. Maternal overweight
or obesity without GDM have been shown to increase the risk of caesarean delivery [12,24,25].
The HAPO study revealed an increased risk of caesarean section in obese primiparous women
with normal glucose tolerance during pregnancy [7]. Our study demonstrates a 1.2-fold risk
for caesarean delivery in overweight and a 1.5-fold risk in obese mothers without GDM. The
concomitant GDM further increased the risk in both groups, as was also seen in previous stud-
ies [7,25,26].
The babies of GDM mothers had a 1.4- to 2.3-fold risk of being admitted to a neonatal
ward. This is consistent with previous literature [18,26]. In a randomized study of intervention
versus routine care after the diagnosis of GDM, Crowther et al. found increased rate of neona-
tal ward admissions in the intervention group [26]. In our study, the babies of GDM mothers
had a 2-fold risk of hypoglycemia compared to the babies in the reference group. This may
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partly be explained by the advice to follow neonatal glycemia; blood glucose concentrations of
babies are followed up routinely when the mother is known to have GDM. However, in our
study the risk of neonatal ward treatment in the babies of GDM women remained increased
after adjustment with neonatal hypoglycemia. The rate of preterm delivery was also increased
in overweight and obese women with GDM and the rate of low 5min Apgar score was
increased in normal weight and obese women with GDM, both of which may lead to increased
need for treatment at neonatal ward.
We found maternal obesity without GDM to be associated with increased risk of treatment
at neonatal ward and also hypoglycemia. These findings are in line with the HAPO study,
which revealed that maternal obesity was independently associated with fetal hyperinsulinemia
and hence an increased risk of neonatal hypoglycemia [7]. Obese pregnant women without a
GDM diagnosis are reported to have higher daytime and nocturnal glucose profiles upon con-
tinuous glucose monitoring compared to women of normal weight, despite diet modification,
which may explain this finding [27]. It is also possible that obese women may become hyper-
glycemic after the conventional screening period at 28 gestational weeks; some of them may be
detected based on glucosuria in routine urine dipstick screening at later antenatal visits and
then referred to OGTT, but for many the condition may remain undetected.
According to our knowledge, there is only one previous study available evaluating the inter-
action effects of GDM and obesity on perinatal outcomes. The study of Hildeń et al. (2019)
revealed no interaction effect between GDM and BMI for severe perinatal outcomes such as
malformations, perinatal mortality, stillbirth, prematurity, low Apgar score, fetal distress or
Erb’s palsy [28]; that study did not asses our primary outcomes. By contrast, we found that
while overweight/obesity alone are associated with macrosomia, caesarean delivery, treatment
at neonatal ward (obesity only), delivery induction and low Apgar score, GDM amplifies these
risks.
In conclusion, we found maternal obesity without GDM to be risk factor for macrosomia,
caesarean delivery and treatment at neonatal ward. Concomitant GDM further amplifies the
risk of macrosomia and caesarean delivery in overweight and obese women. The risk of
macrosomia and caesarean delivery was not significantly increased in counselled normal
weight GDM women when compared to normal weight women without GDM, but their risk
of neonatal morbidity was increased. Our findings urge vigilance in the follow-up of especially
obese women even with normal glucose tolerance. Further, our results underline the impor-
tance of weight management among women of fertile age.
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